Formation Bio
AI-native pharma — accelerating drug development
Biotech
📍 New York, NY
Founded 2016
Current Valuation
$1.7B
as of 2024
UNICORN
Formation Bio (formerly TrialSpark) is an AI-native pharma company that in-licenses drug assets and uses AI plus in-house development to run trials faster and cheaper.
Fundraising Status
private
Founders & Key People
Benjamine Liu
Products
- AI-native drug development platform
Competitors
Eikon Therapeutics · Recursion (RXRX) · Insitro
BiotechAI Drug DevelopmentPharma
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024. Refreshed quarterly.